Skip to main content
Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.785
+0.005 (0.63%)
At close: Apr 28, 2026, 4:00 PM EDT
0.782
-0.003 (-0.42%)
After-hours: Apr 28, 2026, 5:36 PM EDT

Evogene Revenue

In the year 2025, Evogene had annual revenue of $3.85M, down -30.91%. Evogene had revenue of $314.00K in the quarter ending December 31, 2025.

Revenue (ttm)
$3.85M
Revenue Growth
-30.91%
P/S Ratio
2.16
Revenue / Employee
$74,096
Employees
52
Market Cap
8.31M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20253.85M-1.72M-30.91%
Dec 31, 20245.58M2.60M87.02%
Dec 31, 20232.98M1.31M78.03%
Dec 31, 20221.68M745.00K80.11%
Dec 31, 2021930.00K-110.00K-10.58%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

EVGN News

More News